New qPCR test measures TB DNA repeats to improve diagnosis

Tuberculosis testing has been transformed by PCR methods that can quickly pick up Mycobacterium tuberculosis DNA, but not all DNA targets are equally reliable everywhere. One commonly used target, the IS6110 insertion sequence, is highly specific to the M. tuberculosis complex, yet its copy number can vary widely between strains. That variability can make a single-target test miss infections in places where low-copy or IS6110-deficient strains circulate. To tackle this problem, researchers led by Pratap N. Mukhopadhyaya developed a fast quantitative PCR approach to measure exactly how many IS6110 copies are present in clinical samples. They screened 320 cases to find positive specimens and then applied a new assay to those positives to compare IS6110 counts against genome copy estimates from a commercial MPB64-targeted kit. The team built a custom standard curve from a linear DNA fragment representing the IS6110 sequence from the H37Rv strain to make their measurements reliable and comparable. The study focused on whether simple, rapid quantification could expose when IS6110 would be a weak or misleading diagnostic marker in real clinical samples.

The core of the work was a qPCR-based technique designed to quantify IS6110 copy number directly in clinical M. tuberculosis samples and to compare those counts with genome copy numbers estimated by the commercial MPB64-targeted kit. The researchers created a custom standard curve using a linear DNA fragment representing the IS6110 sequence from the H37Rv strain so that qPCR signals could be converted into copy-number estimates. From 320 screened cases, 16 positive samples were analyzed and the results showed major variability in IS6110 content. Most strains had between 15 and 25 copies per genome, confirming high-copy profiles in many samples. However, three samples showed fewer than one IS6110 copy per genome, a pattern the authors attribute to mixed-strain populations dominated by IS6110-deficient bacilli. The study also evaluated workflow improvements: using multiple genetic targets in a single assay and running a dual-target, single-tube multiplex qPCR with dual fluorophores (FAM and VIC) can improve diagnostic accuracy and efficiency. The method demonstrated the feasibility of accurate IS6110 quantification and suggested straightforward routes to automation using simple computational tools.

The findings have practical implications for how laboratories use IS6110 in TB testing. Because copy number can vary so much, relying on IS6110 alone risks false negatives where low-copy or IS6110-deficient strains are present or where mixed infections mask the target. The study argues for regional surveillance of IS6110 prevalence so diagnostic tests can be tailored to local strain patterns rather than assuming one target fits all. Incorporating multiple genetic targets into a single-tube multiplex qPCR and reading them with dual fluorophores (FAM and VIC) offers a way to catch infections that a single target might miss, while improving workflow and reducing hands-on time. The authors also point to the potential for simple computational tools to automate copy-number calculation and help clinicians interpret results more confidently. In short, the work supports a more nuanced, region-specific use of IS6110 for molecular TB diagnostics and shows how modest technical changes can strengthen routine testing.